| Date Filed | Type | Description |
| 08/23/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 08/14/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 06/01/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 05/16/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 05/15/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 04/25/2023 |
8-K
| Quarterly results |
| 04/06/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 04/06/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 03/31/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 02/28/2023 |
RW
| Form RW - Registration Withdrawal Request: |
| 02/14/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/03/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 02/03/2023 |
8-K
| Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive ... |
| 12/28/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 12/28/2022 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits Interac... |
| 12/22/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 12/22/2022 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"VIVEON HEALTH ACQUISITION CORP. Announces that Redemption Reversals in Connection with Vote to Consummate its Initial Business Combination with Suneva Medical, Inc. Are Extended Until December 23, 2022. NEW YORK, Dec. 21, 2022 -- Viveon Health Acquisition Corp. , a special purpose acquisition company , today announced that it will allow those holders of shares of the Company’ s common stock sold as part of the units issued in its initial public offering who elected to redeem their common stock in connection with the special meeting of stockholders held today at 10:30 AM EST , to reverse their redemption requests by sending a DTC DWAC request to the Company’ s transfer agent, Continental Stock Transfer & Trust Company, by 5:00 PM EST on Friday, December 23, 2022. In connection with the Spec..." |
|
| 11/23/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 11/17/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 11/15/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 11/14/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 11/09/2022 |
PRER14A
| Form PRER14A - Preliminary Proxy Soliciting materials: |
| 09/08/2022 |
10-Q/A
| Quarterly Report for the period ended June 30, 2022 [amend] |
| 09/08/2022 |
10-Q/A
| Quarterly Report for the period ended March 31, 2022 [amend] |
| 08/24/2022 |
10-K/A
| Annual Report for the period ended December 31, 2021 [amend] |
| 08/19/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/16/2022 |
8-K
| Quarterly results |
| 08/15/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 08/01/2022 |
SC 13G
| Feis Lawrence reports a 6.1% stake in Viveon Health Acquisition Corp. |
| 07/13/2022 |
S-4
| Form S-4 - Registration of securities, business combinations: |
| 07/13/2022 |
8-K
| Quarterly results |
| 06/10/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
|